ISOFOL MEDICAL (Germany) Top Insiders

5IU Stock  EUR 0.05  0  5.82%   
ISOFOL MEDICAL employs about 6 people. The company is managed by 4 executives with a total tenure of roughly 14 years, averaging almost 3.0 years of service per executive, having 1.5 employees per reported executive. Examination of ISOFOL MEDICAL's management performance can provide insight into the company performance.
Petter Lindqvist  Executive
Chief Officer
Roger MD  Executive
Chief Officer
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ISOFOL MEDICAL AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
ISOFOL MEDICAL AB has a total of 281.11 Million outstanding shares. ISOFOL MEDICAL secures noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as ISOFOL MEDICAL in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of ISOFOL MEDICAL, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

ISOFOL MEDICAL Workforce Comparison

ISOFOL MEDICAL AB is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 10,625. ISOFOL MEDICAL adds roughly 6.0 in number of employees claiming only tiny portion of equities under Health Care industry.

ISOFOL MEDICAL AB Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. ISOFOL MEDICAL AB Price Series Summation is a cross summation of ISOFOL MEDICAL price series and its benchmark/peer.

ISOFOL MEDICAL Notable Stakeholders

An ISOFOL MEDICAL stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ISOFOL MEDICAL often face trade-offs trying to please all of them. ISOFOL MEDICAL's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ISOFOL MEDICAL's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Petter LindqvistChief OfficerProfile
Roger MDChief OfficerProfile
Margareta MBAChief OfficerProfile
John ProffettBusiness OfficerProfile
String symbol = request.getParameter("s");

About ISOFOL MEDICAL Management Performance

The success or failure of an entity such as ISOFOL MEDICAL AB often depends on how effective the management is. ISOFOL MEDICAL management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ISOFOL management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ISOFOL management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Isofol Medical AB , a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden. ISOFOL MEDICAL operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 12 people.

ISOFOL MEDICAL Workforce Analysis

Traditionally, organizations such as ISOFOL MEDICAL use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ISOFOL MEDICAL within its industry.

ISOFOL MEDICAL Manpower Efficiency

Return on ISOFOL MEDICAL Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0

Complementary Tools for ISOFOL Stock analysis

When running ISOFOL MEDICAL's price analysis, check to measure ISOFOL MEDICAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ISOFOL MEDICAL is operating at the current time. Most of ISOFOL MEDICAL's value examination focuses on studying past and present price action to predict the probability of ISOFOL MEDICAL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ISOFOL MEDICAL's price. Additionally, you may evaluate how the addition of ISOFOL MEDICAL to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins